State of the Nation:
Biopharma’s agentic AI moment
The report tests several key hypotheses: whether global pharma leaders truly recognize the value of agentic AI, how much they trust it with critical tasks, and how professionals at different levels of an organization view its potential.
By providing clear, data-driven insights, we aim to offer a guide for pharma companies to understand how their peers are making sense of agentic AI and make strategic decisions to optimize R&D processes and accelerate the development of new treatments for patients.
Read the report
Collaborators

Odd Data and Design Studio partnered with STAT Brand Studio to support data analysis, visualization, and report design.
The studio reviewed the full survey dataset, applied descriptive and comparative analysis to surface key findings, and translated those results into visuals.
In addition to data handling, Odd Data and Design Studio generated and collaborated on the narrative structure of the report, ensuring that the presentation of results aligned with both statistical integrity and readability.

Dr. Radhika Patnala is a neuroscientist, a visual science communicator, and an artist who turns science into powerful stories through art and design.
She founded the science communication and design agencies Sci-illustrate and Endosymbiont, and leads teams to solve design and communication challenges for biotech and pharma.
Her art has been featured by organizations such as UNESCO, the World Health Organization (WHO), and the BBC.

Owkin is an AI company on a mission to unravel thecomplexity of biology. It is building the first Biology Super Intelligence (BASI) by combining powerful biology-specific large language models, multimodal patient data, and agentic software.
At the core of this system is Owkin K, an agentic copilot, and Owkin Zero, a new LLM fine-tuned on biology. Together, they are used by researchers, clinicians, and drug developers to better understand biology, validate scientific hypotheses, and accelerate the development of diagnostics and therapies.
Owkin is launching its agentic software for enterprises - K Pro.